3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Luo et al. Sci China Chem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
oil-bath of 130 °C and stirred for desired time. Then it was
cooled to room temperature, and was released the gas. Then
n-dodecane was added to the reaction solution as an internal
standard for determining the amine conversion and product
yield by gas chromatography with a FID detector and a
nonpolar capillary column (DB-5) (30 m×0.25 mm
46.79, 40.56, 35.34, 33.89, 31.99, 22.35.
N-hexylformamide. H NMR (400 MHz, CDCl ) δ (ppm)
=8.14 (s, 1H), 5.72 (s, 1H), 3.21–3.31 (t, 2H), 1.48–1.53 (m,
2H), 1.24–1.28 (m, 6H), 0.85–0.89 (t, 3H). C NMR
1
3
1
3
(100.6 MHz, CDCl ) δ (ppm)=161.17, 38.21, 31.41, 29.48,
3
26.50, 22.52, 13.98.
N-sec-butylformaide. H NMR (400 MHz, CDCl ) δ (ppm)
1
×
0.25 μm) (GC, Agilent 7890B, USA). High purity nitrogen
3
1
13
was used as a carrier gas. H NMR and C NMR analyses
=8.02, 8.03 (s, 1H), 3.20–3.23 (m, 1H), 1.65 (s, 1H), 1.49–
1.65 (m, 2H), 1.22–1.33 (m, 3H), 0.92–0.95 (m, 3H).
13
were conducted on a Bruker Avance NMR (400 MHz). The
C
1
13
NMR (100.6 MHz, CDCl ) δ (ppm)=160.56, 45.51, 30.78,
H and C NMR data of the resultant compounds are listed
as follows.
3
2
9.58, 22.13, 20.41, 10.26.
N-benzyl-N-methylformamide.
1
1
H
NMR (400 MHz,
N-formylmorpholine. H NMR (400 MHz, CDCl ) δ
ppm)=8.05 (s, 1H), 3.70–3.63 (m, 4H), 3.58–3.55 (t, 2H),
.40–3.37 (t, 2H). C NMR (100.6 MHz, CDCl ) δ (ppm)
3
3
CDCl ) δ (ppm)=8.02, 7.89 (s, 1H), 7.28–6.93 (m, 5H), 4.26
(
3
3
1
3
13
(
m, 1H), 4.13 (s, 1H), 2.58 (s, 3H). C NMR (100.6 MHz,
=
161.52, 67.94, 67.15, 46.50, 41.33.
N-formylpyrrolidine. H NMR (400 MHz, CDCl ) δ (ppm)
CDCl ) δ (ppm)=162.56, 128.91, 128.70, 128.26, 128.11,
3
1
127.64, 127.40, 53.49, 47.79, 34.02, 29.46.
3
1
3
1
=
8.24 (s, 1H), 3.49–3.38 (m, 4H), 1.95–1.86 (m, 4H).
C
N-benzylformamide. H NMR (400 MHz, CDCl
3
) δ (ppm)
NMR (100.6 MHz, CDCl ) δ (ppm)=160.67, 45.80, 42.90,
=8.17 (s, 1H), 7.24–7.32 (m, 5H), 4.41–4.43 (d, 2H), 6.40 (s,
3
1
3
2
4.69, 24.02.
-Formyl-4-methylpiperazine.
CDCl ) δ (ppm)=8.00 (s, 1H), 3.54 (m, 2H), 3.35–3.38 (m,
1H). C NMR (100.6 MHz, CDCl
3
) δ (ppm)=161.22,
1
H
1
NMR (400 MHz,
128.75, 127.75, 127.63, 42.36.
1
N-phenylformamide. H NMR (400 MHz, CDCl
) δ (ppm)
3
3
1
3
13
2
H), 2.38–2.40 (t, 2H), 2.33–2.34 (t, 2H), 2.29 (s, 3H).
C
=8.37 (s, 1H), 7.09–7.56 (m, 5H). C NMR (100.6 MHz,
CDCl ) δ (ppm)=162.77, 159.12, 129.78, 129.13, 125.31,
NMR (100.6 MHz, CDCl ) δ (ppm)=160.87, 55.55, 54.38,
3
3
4
6.28, 45.68, 40.01.
N-formylpiperidine. H NMR (400 MHz, CDCl ) δ (ppm)
124.85, 120.03, 118.84.
N-methyl-N-phenylformamide.
1
1
H
NMR (400 MHz,
3
=
7.89 (s, 1H), 3.38–3.35 (t, 2H), 3.22–3.19 (t, 2H), 1.61–
CDCl ) δ (ppm)=8.36 (s, 1H), 7.05–7.32 (m, 5H), 3.20 (s,
3
13
13
1
.55 (m, 2H), 1.50–1.40 (m, 4H). C NMR (100.6 MHz,
3H). C NMR (100.6 MHz, CDCl
129.60, 126.35, 123.31, 31.97.
) δ (ppm)=162.25,
3
CDCl ) δ (ppm)=160.77, 46.77, 40.55, 26.51, 25.02, 24.62.
3
1
N,N-dipropylformamide. H NMR (400 MHz, CDCl ) δ
3
(
1
ppm)=7.90 (s, 1H), 3.11–3.08 (t, 2H), 3.04–3.00 (t, 2H),
13
.46–1.36 (m, 4H), 0.76–0.72 (m, 6H).
C NMR
3 Results and discussion
(
2
100.6 MHz, CDCl ) δ (ppm)=162.63, 48.99, 43.59, 21.69,
3
3
.1 Characterization of the Pd catalysts
0.40, 11.03.
N,N-dihexylformamide. H NMR (400 MHz, CDCl ) δ
1
The N contents of the resultant NC-T-x were first examined
by elemental analysis. With the same mass ratio of glucose to
melamine at 2:1, the N contents in NC-T-x decreased with
the calcining temperature increase, and the sample prepared
at 800 °C possessed an N content of 6.9%. The sample
prepared with the mass ratio of glucose to melamine at 3:1
and 20:1 at 800 °C possessed N contents at 4.9% and 1.0%,
respectively.
The XRD patterns of NC-800-6.9%, Pd/NC-800-6.9%, C-
800, Pd/C-800 are shown in Figure 1(a). Both NC-800-6.9%
and C-800 showed two broad peaks at about 2θ=23° and 44°
with low intensity, which might be attributed to the partly
graphitic carbon [36,37]. No obvious characteristic diffrac-
tion peaks assigning to Pd particles were detected in the
XRD patterns of Pd/NC-800-6.9% and Pd/C-800, pre-
sumably due to the tiny size of Pd particles with the weak
crystallization, as well as low loading contents [38]. Figure
1(b) shows a TEM image of Pd/NC-800-6.9% with corre-
sponding histogram of particles distribution. It is clear that
the Pd nanoparticles with average size<2.0 nm were uni-
3
(ppm)=7.99 (s, 1H), 3.21–3.25 (t, 2H), 3.13–3.16 (t, 2H),
1
3
1
.47–1.48 (m, 4H), 1.25 (m, 12H), 0.84–0.86 (m, 6H). C
NMR (100.6 MHz, CDCl ) δ (ppm)=161.66, 46.46, 41.14,
3
1
3
0.54, 30.39, 27.66, 26.29, 25.63, 25.16, 21.56, 21.53, 12.99,
2.95.
1
N-cyclopentylformamide. H NMR (400 MHz, CDCl ) δ
3
(ppm)=7.89 (s, 1H), 3.69–3.64 (m, 1H), 1.84–1.76 (m, 2H),
13
1
.56–1.41 (m, 4H), 1.32–1.25 (m, 2H). C NMR (100.6,
MHz CDCl ) δ (ppm)=163.95, 54.02, 32.56, 32.02, 23.12,
2
3
3.00.
N-cyclohexylformamide. H NMR (400 MHz, CDCl ) δ
1
3
(ppm)=8.09 (s, 1H), 5.74–5.55 (s, 1H), 3.89–3.81 (m,
13
0
(
2
.76H), 3.26-3.33 (m, 0.28H), 1.11–1.94 (m, 10H). C NMR
100.6 MHz, CDCl ) δ (ppm)=161.97, 47.09, 34.71, 33.05,
3
5.43, 24.73.
1
N-butylformamide. H NMR (400 MHz, CDCl ) δ (ppm)
3
=
8.13 (s, 1H), 5.74 (s, 1H), 3.24–3.29 (m, 1.6H), 3.16–3.21
(m, 0.4H), 1.47–1.50 (m, 2H), 1.31–1.36 (m, 2H), 0.88–0.92
13
(m, 3H). C NMR (100.6 MHz, CDCl ) δ (ppm)=161.4,
3